Gene transfer into canine myoblasts. 1999

S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
TRANSGENE S.A., 11 rue de Molsheim, 67082, Strasbourg Cedex, France.

We have developed and characterized cultures of healthy and dystrophic canine myoblasts for the evaluation of various gene transfer protocols. The number of desmin-positive myoblasts was elevated (>>80%) in cultures of myoblasts obtained from different muscle territories, the diaphragm muscle giving rise to the purest cultures. Myoblasts from dogs turned out to be a very convenient source of well transfectable and transducible cells. Transfection with plasmid DNA allowed efficient transgene expression (50% of beta-galactosidase positive cells and about 375 ng luciferase/mg protein after transfection with a calcium phosphate-precipitated plasmid). Infection with high concentrations of adenoviral and retroviral vectors allowed transgene (beta-galactosidase or mini-dystrophin) detection in about 75 to 90% of the canine cells. Therefore, primary dog myoblast cultures represent a useful in vitro model for viral and non-viral gene delivery, as well as for functional evaluation and cell grafting with applications in genetic diseases, vaccination or production of circulating therapeutic proteins.

UI MeSH Term Description Entries

Related Publications

S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
August 1994, Human gene therapy,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
February 1995, Biochemical and biophysical research communications,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
May 1995, Journal of neurochemistry,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
January 1998, The Journal of thoracic and cardiovascular surgery,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
January 2007, Neurosurgery,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
July 1997, Neuromuscular disorders : NMD,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
April 1993, Human gene therapy,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
October 1999, Neurology,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
July 1995, Cardiovascular research,
S Braun, and C Thioudellet, and F Perraud, and C Escriou, and M C Claudepierre, and H Homann, and M Lusky, and M Mehtali, and R Bischoff, and A Pavirani
December 1995, Arteriosclerosis, thrombosis, and vascular biology,
Copied contents to your clipboard!